| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.054 | 0.4 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.05 | 0.4 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |